Abstract Details
Activity Number:
|
632
|
Type:
|
Topic Contributed
|
Date/Time:
|
Thursday, August 7, 2014 : 10:30 AM to 12:20 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract #311252
|
View Presentation
|
Title:
|
Biomarker Driven Population Enrichment for Adaptive Oncology Trials
|
Author(s):
|
Cyrus Mehta*+
|
Companies:
|
Cytel
|
Keywords:
|
predictive biomarkers ;
subgroup selection ;
adaptive design ;
control of alpha
|
Abstract:
|
The development of molecularly targeted therapies for certain types of cancers has led to the consideration of population enrichment designs that explicitly factor-in the possibility that the experimental compound might differentially benefit different biomarker subgroups. In such designs, enrollment would initially be open to a broad patient population with the option to restrict future enrollment, following an interim analysis, to only those biomarker subgroups that appeared to be benefiting from the experimental therapy. This strategy poses several statistical and logistical design challenges, especially for late-stage oncology trials that are are typically event driven. We present new statistical methodology for population enrichment designs based on generalizations of the conditional error rate approaches of Muller and Schafer. The special difficulties encountered with time-to-event endpoints are addressed by our methods. The crucial role of simulation for guiding the choice of design parameters is emphasized.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2014 program
|
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.